‹ All stocks
Filana Therapeutics
FLNA · NASDAQ · Healthcare
$0.89
▼ $0.89 (-3.26%)
Day range
$0.89 – $0.93
Year range
$0.67 – $2.49
Open
$0.92
Previous close
—
Market cap
$42.99M
Volume (24h)
$186.2K
Volume (52w)
$165.73K
Performance
7D
▲ 4.31%
1M
▲ 11.64%
3M
▼ -32.06%
6M
▼ -47.65%
1Y
▼ -56.59%
YTD
▼ -56.59%
3Y
▼ -56.59%
5Y
▼ -56.59%
All-time
▼ -56.59%
Key statistics
P/E ratio
-1.02
EPS (TTM)
$-0.87
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
48.3M
About Filana Therapeutics
Filana Therapeutics, Inc. is a company dedicated to pioneering new pharmaceutical products and diagnostic technologies. A key area of its research is focused on creating potential treatments for Alzheimer's disease, including the investigational compounds PTI-125 and PTI-125Dx. Established by Remi Barbier in May 1998, the firm maintains its principal office in Austin, Texas.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |